Alzheimer’s Drugs Debate Grows Over £90K Cost
A fresh analysis is raising concerns about whether recently developed Alzheimer’s treatments deliver meaningful benefits for patients, despite earlier optimism surrounding their arrival. The findings suggest that while the drugs represent scientific progress, their real world impact may fall short of expectations. New analysis questions whether widely discussed treatments meaningfully improve patients lives. The treatments, […]